With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results